A nanomedicine strategy for detecting and modulating protease activity in vivo [ 2012 - 2015 ]

Research Grant

Researchers: Prof John Gooding (Principal investigator) ,  Prof Denis Wakefield ,  Prof Nick Di Girolamo

Brief description Protease enzymes are vitally important for normal bodily function but can play a deleterious role in many diseases such as cancer, aging diseases and eye diseases. The proposed research will provide a nanomedicine solution to the detection and therapeutic control of protease activity in vivo using nanoporous optical devices that are benign to the body. This general strategy for will be demonstrated in eyes with a view to detection and treating the eye disease uveitis.

Funding Amount $AUD 455,534.21

Funding Scheme Project Grants

Notes Standard Project Grant